The Effect of Pharmacist Intervention on Blood Pressure Control

Pharmacist Intervention Effect on the Medication Adherence and Blood Pressure Control in Treated Patients

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01233193

Acronym

AFenPA

Enrollment

140

Registered

2010-11-03

Start date

2010-02-28

Completion date

2011-09-30

Last updated

2016-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

Home blood pressure measurement, Pharmaceutical Services, Medication adherence, hypertension management, Blood Pressure

Brief summary

The purpose of the study is to test if a Pharmacist Intervention Program with home blood pressure monitoring (HBPM) improves or controls pharmacological adherence and blood pressure levels in hypertensive patients under pharmacological treatment, compared to those who receive usual care in a community pharmacy setting.

Detailed description

Hypertension is a major health concern worldwide due to its deleterious impact on the population in terms of excessive morbidity and mortality, especially when there is insufficient hypertension control and prevention at the community level.

Interventions

BEHAVIORALHealth education, Home blood pressure monitoring

Health education (on hypertension, smoking, healthy diet, obesity, physical inactivity and adherence to antihypertensive medications and home blood pressure monitoring) . The patient will be referred to physician when needed. The patient will be followed up during 6 months.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients of both genders between the ages of 18 and 80 years, who access the pharmacy to fill their own prescription for hypertension.

Exclusion criteria

* Patient living with an other Hypertensive patient treated with the same medications * Pregnant women * Hypertensive patients with levels of systolic/diastolic blood pressure ≥ 180mmHg/110mmHg * Patient with secondary hypertension, kidney or liver failure * Patients already included in a care program for hypertensive patients * Patients with a new treatment for hypertension (less than 1 month)

Design outcomes

Primary

Measure	Time frame	Description
blood pressure control	At 6 months	Percentage of patients with controlled hypertension

Secondary

Measure	Time frame	Description
Adherence	At 6 months	Percentage of adherent patients after 6 months within the trial

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026